Saratov JOURNAL of Medical and Scientific Research

Smotrova Yu.N.

Saratov State Medical University n. a. V.I. Razumovsky Associate Professor of Department of Economics and Management of Healthcare and Pharmacy, PhD

Rheumatology profile patients adherence to treatment with non-steroidal anti-inflammatory drugs

Year: 2020, volume 16 Issue: №1 Pages: 99-103
Heading: Sociology of Medicine Article type: Original article
Authors: Smotrova Yu.N., Novokreshchenova I.G., Akulova A.I.
Organization: Saratov State Medical University
Summary:

The aim of the study is to assess the degree of adherence of patients with rheumatic diseases to the treatment of non-steroidal anti-inflammatory drugs (NSAIDs). Material and Methods. 196 patients were surveyed using a specially designed questionnaire, which included Morisky — Green test. Statistical data processing was carried out by methods nonparametric statistics (criterion x2)- Results. Patients took NSAIDs in rheumatoid arthritis (50.0%), ankylosing spon-dylitis (37.8%), vertebrogenic dorsalgia (20.4%). 49.0% of patients took NSAIDs constantly, 39.3% — during courses of treatment, 11.7% — on demand (in pain). 81.1 % of patients were engaged in self-treatment of NSAIDs. 20 patients (10.2%) were adherent to the treatment of NSAIDs, 29 patients (14.8%) were insufficiently adherent (patients were united in one group), 147 patients (75.0%) were not adherent to the treatment. Non-adherent patients mostly violated the regimen of treatment if they felt well (85.7%). For adherent patients the most significant motive was deterioration after taking NSAID (20.4%). Adherent patients mostly had higher education in relation to non-adherent (71.4 and 53.7% respectively) (x2=6.647; p<0.05). Side effects of NSAIDs were absent in 73.5% of adherent patients and in 32,0% of non-adherent (x2=24.795; p<0.01). Conclusion. The level of education, the frequency of side effects and subjective assessment of the patient's state of health affect the degree of adherence of patients with rheumatic diseases to the treatment of NSAIDs.

AttachmentSize
2020_01_099-103.pdf297.41 KB